Irving Investors — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
LUMICKS develops life science research tools that measure and apply forces around biological interactions to link structural and 'omics analysis to functional outcomes at the molecular and cellular level.
BiotechDeep TechHardwareMedical Devices
Andrea(Co-founder & Chief Scientific Officer)Gerrit(Co-founder & Director of Product Management and Marketing)Hugo(CEO)Edmee(Chief Financial Officer)Hannah(HR Director)
Co-investorsLauxera Capital PartnersSoftBank Vision FundEuropean Investment BankGilde HealthcarePura Vida InvestmentsT. Rowe Price
Model Medicines is an AI-powered biotechnology company that uses computation to discover and engineer small molecule drugs targeting disease-driving biological mechanisms.
AI & Machine LearningBiotechDeep TechDigital HealthLa Jolla, US
Daniel Haders(Executive Officer, Director)inDaniel Haders II, Ph.D(Founder, CEO)inSean Russell(Founder, Chief Operating Officer)inKip Quackenbush(Executive Officer, Director)inMarlon Evans(Executive Officer, Director)in
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.